Prognostic Values of C-Reactive Protein Levels on Clinical Outcome After Implantation of Sirolimus-Eluting Stents in Patients on Hemodialysis
Author(s) -
Hideki Ishii,
Takanobu Toriyama,
Toru Aoyama,
Hiroshi Takahashi,
Tetsuya Amano,
Mutsuharu Hayashi,
Miho Tanaka,
Yoshihiro Kawamura,
Yoshinari Yasuda,
Yukio Yuzawa,
Shoichi Maruyama,
Seiichi Matsuo,
Tatsuaki Matsubara,
Toyoaki Murohara
Publication year - 2009
Publication title -
circulation cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.621
H-Index - 95
eISSN - 1941-7632
pISSN - 1941-7640
DOI - 10.1161/circinterventions.109.889915
Subject(s) - medicine , conventional pci , percutaneous coronary intervention , cardiology , restenosis , hemodialysis , myocardial infarction , drug eluting stent , sirolimus , stent , revascularization
Percutaneous coronary intervention (PCI) using drug-eluting stents significantly reduces the risk of restenosis in the general population. However, in patients on hemodialysis, adverse cardiac events are frequently seen even if treated with drug-eluting stents. Recent studies suggest that C-reactive protein (CRP) reflects vascular wall inflammation and can predict adverse cardiac events. We evaluated possible prognostic values of CRP on outcomes in patients on hemodialysis undergoing PCI with drug-eluting stents.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom